FDA Inspection 1228619 — RadMD
The FDA completed an inspection of RadMD on January 24, 2024 in Conshohocken, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Conshohocken, PA (United States)
Additional Details
Sponsor, Contract Research Organization